Alavi, M., Mozafari, M. R., Ghaemi, S., Ashengroph, M., Hasanzadeh Davarani, F., & Mohammadabadi, M. (2022). Interaction of epigallocatechin gallate and quercetin with spike glycoprotein (S-glycoprotein) of SARS-CoV-2: In silico study.
Biomedicines, 10(12), e3074.
https://doi.org/10.3390/biomedicines10123074
Ali, A. H., Petroski, G. F., Diaz-Arias, A. A., Al Juboori, A., Wheeler, A. A., Ganga, R. R., Pitt, J. B., Spencer, N. M., Hammoud, G. M., Rector, R. S., Parks, E. J., & Ibdah, J. A. (2021). A model incorporating serum alkaline phosphatase for prediction of liver fibrosis in adults with obesity and nonalcoholic fatty liver disease.
Journal of Clinical Medicine, 10(15), 3311.
https://doi.org/10.3390/jcm10153311
Amiri Roudbar, M., Mohammadabadi, M. R., Ayatollahi Mehrgardi, A., Abdollahi-Arpanahi, R., Momen, M., Morota, G., Brito Lopes, F., Gianola, D., & Rosa, G. J. M. (2020). Integration of single nucleotide variants and whole-genome DNA methylation profiles for classification of rheumatoid arthritis cases from controls.
Heredity, 124(5), 658-674.
https://doi.org/10.1038/s41437-020-0301-4
Arabpour, Z., Mohammadabadi, M., & Khezri, A. (2021). The expression pattern of p32 gene in femur, humeral muscle, back muscle and back fat tissues of Kermani lambs.
Agricultural Biotechnology Journal,
13(4), 183-200.
https://doi.org/10.22103/jab.2022.18782.1371
Buchynskyi, M., Oksenych, V., Kamyshna, I., Vorobets, I., Halabitska, I., & Kamyshnyi, O. (2024). Modulatory roles of AHR, FFAR2, FXR, and TGR5 gene expression in metabolic-associated fatty liver disease and COVID-19 outcomes.
Viruses, 16(6), 985.
https://doi.org/10.3390/v16060985
Carlier, A., Phan, F., Szpigel, A., Hajduch, E., Salem, J. E., Gautheron, J., Le Goff, W., Guérin, M., Lachkar, F., Ratziu, V., Hartemann, A., Ferré, P., Foufelle, F., & Bourron, O. (2020). Dihydroceramides in triglyceride-enriched VLDL are associated with nonalcoholic fatty liver disease severity in type 2 diabetes.
Cell Reports Medicine, 1(9), 100154.
https://doi.org/10.1016/j.xcrm.2020.100154
Chen, C., Zhu, Z., Mao, Y., Xu, Y., Du, J., Tang, X., & Cao, H. (2020). HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.
Bioscience Reports, 40(1), BSR20193996.
https://doi.org/10.1042/BSR20193996
Choochuay, K., Kunhapan, P., Puangpetch, A., Tongsima, S., Srisawasdi, P., Sobhonslidsuk, A., Sungkanuparph, S., Biswas, M., & Sukasem, C. (2024). Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus.
World Journal of Hepatology, 16(3), 366–378.
https://doi.org/10.4254/wjh.v16.i3.366
Eslam, M., Sanyal, A. J., George, J., & International Consensus Panel. (2020). MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.
Gastroenterology, 158(7), 1999–2014.e1.
https://doi.org/10.1053/j.gastro.2019.11.312
Hajalizadeh, Z., Dayani, O., Khezri, A., Tahmasbi, R., Mohammadabadi, M., Solodka, T., Kalashnyk, O., Afanasenko, V., & Babenko, O. (2021). Expression of calpastatin gene in Kermani sheep using real-time PCR.
Journal of Livestock Science and Technologies,
9(2), 51-57.
https://doi.org/10.22103/jlst.2021.18165.1381
Heidarpour, F., Mohammadabadi, M. R., Zaidul, I. S. M., Maherani, B., & Saari, N. (2011). Use of prebiotics in oral delivery of bioactive compounds: A nanotechnology perspective.
Pharmazie, 66(5), 319-324.
https://pubmed.ncbi.nlm.nih.gov/21699064/
Hou, X., Guan, Y., Tang, Y., Song, A., Zhao, J., Ren, L., Chen, S., Wei, L., Ma, H., & Song, G. (2021). A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test.
Lipids in Health and Disease, 20(1), 54.
https://doi.org/10.1186/s12944-021-01483-z
Huang, C., Seah, J. J., Tan, C. K., Kam, J. W., Tan, J., Teo, E. K., Kwek, A., Wong, Y. J., Tan, M., Ang, T. L., & Kumar, R. (2021). Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
Clinical Research in Hepatology and Gastroenterology, 45(4), 101528.
https://doi.org/10.1016/j.clinre.2020.08.006
Imamura, Y., Mawatari, S., Oda, K., Kumagai, K., Hiramine, Y., Saishoji, A., Kakihara, A., Nakahara, M., Oku, M., Hosoyamada, K., Kanmura, S., Moriuchi, A., Miyahara, H., & Ido, A. (2021). Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: A cross-sectional study.
Hepatology Research, 51(5), 570–579.
https://doi.org/10.1111/hepr.13631
Khabiri, A., Toroghi, R., Mohammadabadi, M., & Tabatabaeizadeh, S. E. (2023). Introduction of a Newcastle disease virus challenge strain (sub-genotype VII.1.1) isolated in Iran.
Veterinary Research Forum, 14(4), 221.
https://doi.org/10.30466/vrf.2022.548152.3373
Kong, L., Chen, J., Ji, X., Qin, Q., Yang, H., Liu, D., Li, D., & Sun, M. (2021). Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
Journal of Experimental & Clinical Cancer Research, 40(1), 18.
https://doi.org/10.1186/s13046-020-01782-w
Li, Z., Zhang, B., Liu, Q., Tao, Z., Ding, L., Guo, B., Zhang, E., Zhang, H., Meng, Z., Guo, S., Chen, Y., Peng, J., Li, J., Wang, C., Huang, Y., Xu, H., & Wu, Y. (2023). Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease.
EBioMedicine, 90, 104543.
https://doi.org/10.1016/j.ebiom.2023.104543
Lin, H., Yip, T. C., Zhang, X., Li, G., Tse, Y. K., Hui, V. W., Liang, L. Y., Lai, J. C., Chan, S. L., Chan, H. L., Wong, G. L., & Wong, V. W. (2023). Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.
Hepatology, 77(2), 573–584.
https://doi.org/10.1002/hep.32633
Liu, H., He, B., Hu, W., Liu, K., Dai, Y., Zhang, D., & Wang, H. (2021). Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway.
Biochemical Pharmacology, 185, 114420.
https://doi.org/10.1016/j.bcp.2021.114420
Liu, J., Peng, H., Wang, C., Wang, Y., Wang, R., Liu, J., Zhou, T., & Yao, S. (2023). Correlation between the severity of metabolic dysfunction-associated fatty liver disease and serum uric acid to serum creatinine ratio.
International Journal of Endocrinology, 2023, 6928117.
https://doi.org/10.1155/2023/6928117
Lu, S., Xie, Q., Kuang, M., Hu, C., Li, X., Yang, H., Sheng, G., Xie, G., & Zou, Y. (2023). Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: Evidence from a mediation analysis.
Journal of Translational Medicine, 21(1), 192.
https://doi.org/10.1186/s12967-023-04047-0
Ma, X., Liu, S., Zhang, J., Dong, M., Wang, Y., Wang, M., & Xin, Y. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: A systematic review and meta-analysis.
BMC Gastroenterology, 20(1), 10.
https://doi.org/10.1186/s12876-020-1165-z
Mocciaro, G., Allison, M., Jenkins, B., Azzu, V., Huang-Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Susan, D., Frontini, M., Vidal-Puig, A., Koulman, A., Griffin, J. L., & Vacca, M. (2023). Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL).
Molecular Metabolism, 73, 101728.
https://doi.org/10.1016/j.molmet.2023.101728
Mohamadinejad, F., Mohammadabadi, M., Roudbari, Z., Eskandarynasab Siahkouhi, S., Babenko, O., Klopenko, N., Borshch, O., Starostenko, I., Kalashnyk, O., & Assadi Soumeh, E. (2024). Analysis of liver transcriptome data to identify the genes affecting lipid metabolism during the embryonic and hatching periods in ROSS breeder broilers.
Journal of Livestock Science and Technologies,
12(2), 61-67.
https://doi.org/10.22103/jlst.2024.23814.1554
Mohammadabadi, M., Afsharmanesh, M., Khezri, A., Kheyrodin, H., Babenko, O. I., Borshch, O., Kalashnyk, O., Nechyporenko, O., Afanasenko, V., Slynko, V., & Usenko, S. (2025). Effect of mealworm on GBP4L gene expression in the spleen tissue of Ross broiler chickens. Agricultural Biotechnology Journal, 17(2), 343–360. https://doi.org/10.22103/jab.2025.25277.1714
Mohammadabadi, M., Babenko, I., Borshch, O., Kalashnyk, O., Ievstafiieva, Y., & Buchkovska, V. (2024). Measuring the relative expression pattern of the
UCP2 gene in different tissues of the Raini Cashmere goat.
Agricultural Biotechnology Journal, 16(3), 317-332.
https://doi.org/10.22103/jab.2024.24337.1627
Mohammadabadi, M., Golkar, A., & Askari Hesni, M. (2023). The effect of fennel (
Foeniculum vulgare) on insulin-like growth factor 1 gene expression in the rumen tissue of Kermani sheep.
Agricultural Biotechnology Journal, 15(4), 239-256.
https://doi.org/10.22103/jab.2023.22647.1530
Mohammadabadi, M., Kheyrodin, H., Latifi, A., & Babenko Ivanivna, O. (2022a). mRNA expression profile of DNAH1 gene in testis tissue of Raini Cashmere goat.
Agricultural Biotechnology Journal,
14(3), 243-256.
https://doi.org/10.22103/jab.2022.20199.1428
Mohammadabadi, M., Shaban Jorjandy, D., Arabpoor Raghabadi, Z., Abareghi, F., Sasan, H. A., & Bordbar, F. (2022b). The role of fennel on DLK1 gene expression in sheep heart tissue.
Agricultural Biotechnology Journal,
14(2), 155-170.
https://doi.org/10.22103/jab.2022.19402.1399
Noori, A. N., Behzadi, M. R. B., & Mohammadabadi, M. R. (2017). Expression pattern of Rheb gene in Jabal Barez Red goat.
The Indian Journal of Animal Sciences,
87(11), 1375–1378.
https://doi.org/10.56093/ijans.v87i11.75890
Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., Yong, J. N., Zeng, R. W., Chew, N. W. S., Nah, B., Kulkarni, A., Siddiqui, M. S., Dan, Y. Y., Wong, V. W., Sanyal, A. J., … Ng, C. H. (2023). Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis.
The Lancet Gastroenterology & Hepatology, 8(1), 20–30.
https://doi.org/10.1016/S2468-1253(22)00317-X
Rajapaksha, I. G., Gunarathne, L. S., Asadi, K., Laybutt, R., Andrikopoulous, S., Alexander, I. E., Watt, M. J., Angus, P. W., & Herath, C. B. (2022). Angiotensin converting enzyme-2 therapy improves liver fibrosis and glycemic control in diabetic mice with fatty liver.
Hepatology Communications, 6(5), 1056–1072.
https://doi.org/10.1002/hep4.1884
Rezamand, G., Mahmoudi, T., Tabaeian, S. P., Farahani, H., Shahinmehr, F., Nobakht, H., Dabiri, R., Asadi, A., Mansour-Ghanaei, F., & Zali, M. R. (2021). The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.
Physiological International, 108(3), 342–352.
https://doi.org/10.1556/2060.2021.00183
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., Arrese, M., Bataller, R., Beuers, U., Boursier, J., Bugianesi, E., Byrne, C. D., Castro Narro, G. E., Chowdhury, A., Cortez-Pinto, H., … Newsome, P. N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology, 78(6), 1966–1986.
https://doi.org/10.1097/HEP.0000000000000520
Roudbar, M.A., Mohammadabadi, M., & Salmani, V. (2015). Epigenetics: A new challenge in animal breeding. Genetics in the Third Millennium, 12(4), 3900–3914.
Safaei, S. M. H., Dadpasand, M., Mohammadabadi, M., Atashi, H., Stavetska, R., Klopenko, N., & Kalashnyk, O. (2022). An
Origanum majorana leaf diet influences
Myogenin gene expression, performance, and carcass characteristics in lambs.
Animals, 13(1), 14.
https://doi.org/10.3390/ani13010014
Safaei, S. M. H., Mohammadabadi, M., Moradi, B., Kalashnyk, O., Klopenko, N., Babenko, O., Borshch, O. O., & Afanasenko, V. (2024). Role of fennel (
Foeniculum vulgare) seed powder in increasing testosterone and
IGF1 gene expression in the testis of lamb.
Gene Expression, 23(2), 98-105.
https://doi.org/10.14218/GE.2023.00020
Shahsavari, M., Mohammadabadi, M., Khezri, A., Borshch, O., Babenko, O., Kalashnyk, O., Afanasenko, V., & Kondratiuk, V. (2022). Effect of fennel (
Foeniculum vulgare) seed powder consumption on
insulin-like growth factor 1 gene expression in the liver tissue of growing lambs.
Gene Expression, 21(2), 21-26.
https://doi.org/10.14218/GE.2022.00017
Shiha, G., Korenjak, M., Eskridge, W., Casanovas, T., Velez-Moller, P., Högström, S., Richardson, B., Munoz, C., Sigurðardóttir, S., Coulibaly, A., Milan, M., Bautista, F., Leung, N. W. Y., Mooney, V., Obekpa, S., Bech, E., Polavarapu, N., Hamed, A. E., Radiani, T., … Eslam, M. (2021). Redefining fatty liver disease: An international patient perspective.
The Lancet Gastroenterology & Hepatology, 6(1), 73–79.
https://doi.org/10.1016/S2468-1253(20)30294-6
Shokri, S., Khezri, A., Mohammadabadi, M., & Kheyrodin, H. (2023). The expression of MYH7 gene in femur, humeral muscle and back muscle tissues of fattening lambs of the Kermani breed.
Agricultural Biotechnology Journal,
15(2), 217-236.
https://doi.org/10.22103/jab.2023.21524.1486
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., Sirlin, C. B., Talukdar, S., Hellerstein, M. K., & Klein, S. (2020). Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Journal of Clinical Investigation, 130(3), 1453–1460.
https://doi.org/10.1172/JCI134165
Sveinbjornsson, G., Ulfarsson, M. O., Thorolfsdottir, R. B., Jonsson, B. A., Einarsson, E., Gunnlaugsson, G., Rognvaldsson, S., Arnar, D. O., Baldvinsson, M., Bjarnason, R. G., DBDS Genomic Consortium, Eiriksdottir, T., Erikstrup, C., Ferkingstad, E., Halldorsson, G. H., Helgason, H., Helgadottir, A., Hindhede, L., Hjorleifsson, G., … Stefansson, K. (2022). Multiomics study of nonalcoholic fatty liver disease.
Nature Genetics, 54(11), 1652–1663.
https://doi.org/10.1038/s41588-022-01199-5
Tabaeian, S. P., Mahmoudi, T., Sabzikarian, M., Rezamand, G., Dabiri, R., Nobakht, H., Asadi, A., Farahani, H., Mansour-Ghanaei, F., & Zali, M. R. (2021). The Leu72Met (rs696217 G>T) polymorphism of the ghrelin gene might be a protective factor for nonalcoholic fatty liver disease.
Journal of Gastrointestinal and Liver Diseases, 30(2), 233–239.
https://doi.org/10.15403/jgld-2703
Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023). Global incidence and prevalence of nonalcoholic fatty liver disease.
Clinical and Molecular Hepatology, 29(Suppl), S32–S42.
https://doi.org/10.3350/cmh.2022.0365
Tuero, C., Becerril, S., Ezquerro, S., Neira, G., Frühbeck, G., & Rodríguez, A. (2023). Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression.
Journal of Physiology and Biochemistry, 79(4), 833–849.
https://doi.org/10.1007/s13105-022-00933-1
Wang, Z., Du, H., Zhao, Y., Ren, Y., Ma, C., Chen, H., Li, M., Tian, J., Xue, C., Long, G., Xu, M., & Jiang, Y. (2023). Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials.
Frontiers in Endocrinology, 14, 1111430.
https://doi.org/10.3389/fendo.2023.1111430
Yang, M., Ma, X., Xuan, X., Deng, H., Chen, Q., & Yuan, L. (2020). Liraglutide attenuates non-alcoholic fatty liver disease in mice by regulating the local renin-angiotensin system.
Frontiers in Pharmacology, 11, 432.
https://doi.org/10.3389/fphar.2020.00432
Yang, Y., Cai, J., Yang, X., Wang, K., Sun, K., Yang, Z., Zhang, L., Yang, L., Gu, C., Huang, X., Wang, Z., & Zhu, X. (2022). Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Molecular Therapy, 30(6), 2342–2353.
https://doi.org/10.1016/j.ymthe.2022.02.021
Zhang, C., Xu, Q., Xu, C., Yang, K., Xia, T., Hasi, W., Hao, M., & Kuang, H. (2024). Sex differences in the association between AST/ALT and incidence of type 2 diabetes in Japanese patients with nonalcoholic fatty liver disease: A retrospective cohort study.
Endocrine Research, 49(1), 1–11.
https://doi.org/10.1080/07435800.2023.2262034
)